Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a life sciences company specializing in preparedness and response solutions for public health threats in the United States. The company's products include vaccines for anthrax and smallpox, treatments for botulism and opioid overdose, as well as vaccines for typhoid fever, cholera, and influenza. Additionally, it is developing a range of products such as sustained release injections for opioid use disorder, universal influenza vaccines, and antidotes for cyanide poisoning. Emergent BioSolutions also offers contract development and manufacturing services for drug substance and product manufacturing, packaging, and technology transfer.

Products

• Anthrax and smallpox vaccines

• Opioid overdose treatments

• Vaccines for typhoid fever, cholera, and influenza

• Contract development and manufacturing services